A 2015 study found by 2050, Earth will need to increase crop yields by between 60% and 110% to sustain a rapidly expanding human populace.
-
-
A Closer Look: ThinkMyco pushes the button on magic mushroom market
Psilocybin and other psychedelics are forcing their way out of prohibition as potentially viable treatments for not only depression and anxiety but also Alzheimer’s and other neurodegenerative diseases plaguing millions in North America alone. In the end, psilocybin solutions address a $300 billion dollar psychotherapy and wellness global market.
-
ShroomStocks video: Magic mushrooms 101
Psilocybin is becoming the new cannabis as psychedelic mushrooms find themselves in therapeutic use. What began as a ritual embibement thousands of years ago, could help doctors treat the human mind non-intrusively with an unheard of efficacy. The chemistry behind these little buttons of laughter could disrupt the treatment of conditions such as depression and anxiety as well as substance abuse.
